21 patents
Utility
Power Unit for Drug Delivery Device
25 Nov 20
The present invention provides a power unit (1) for a drug delivery device as well as methods for providing and mounting the power unit (1) in the drug delivery device.
Noekkvi Steinn Sigurdarson, Nicolai Michael Jensen
Filed: 19 Nov 18
Utility
An Injection Device With Needle Cleaning
18 Nov 20
The invention relates to a medical injection device having a needle cannula for multiple use and which needle cannula is cleaned between subsequent injections.
Simon Munch Pedersen, Bo Radmer
Filed: 18 Nov 18
Utility
Drug Injection Device with Deflectable Transducer
18 Nov 20
The present invention provides a drug injection device (100, 100′, 100″) comprising a first element (130) and a second element (102, 102′, 102″) configured to undergo movement relative to each other corresponding to an action performed on or by the drug injection device (100, 100′, 100″), wherein the first element (130) comprises serially disposed protrusions (133), and wherein the second element (102, 102′, 102″) comprises a second element base and a deflectable transducer (170, 170′, 170″).
Nikolaj Eusebius Jakobsen, Per Einar Pontus Holm
Filed: 1 Feb 19
Utility
Tolerogenic DNA Vaccine
28 Oct 20
The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
Jay Chaplin, Michael Wijaranakula
Filed: 25 Apr 19
Utility
Syringe holder for a medical injector and method of forming a medical injector assembly
21 Oct 20
A syringe holder (200) comprising: a body (210) extending along a central longitudinal axis and adapted to receive the barrel (110) of a syringe (100), wherein the body (210) includes at least two body sections (240) disposed around the central longitudinal axis, the body sections (240, 240A, 240B) having distal ends with shoulder sections (250) adapted for being received in a circumferential gap (150) between the barrel (110) of the syringe (100) and a needle shield (120) covering a needle (130) of the syringe to retain the syringe (100) so as to prevent the syringe from moving distally (D) relative to the syringe holder (200), wherein the body (210) further comprises a plurality of expandable connector arrangements (230) each interconnecting pairs of the at least two body sections (240, 240A, 240B) so that the body sections (240, 240A, 240B) and the expandable connector arrangements (230) form a closed loop in the circumferential direction around the barrel (110) of a syringe (100) held by the body (210), wherein the expandable connector arrangements (230) are so configured that the body sections (240, 240A, 240B) are movable between a non-retaining position and a retaining position.
Lars Peter Klitmose, Ebbe Kiilerich
Filed: 23 Oct 18
Utility
Drug Delivery System with Multipolar Magnet and Sensor System
21 Oct 20
A drug delivery system comprises an indicator element and a sensor system.
Laurits Hoejgaard Olesen, Henrik Bengtsson, Leif Johannsen, Keld Baden-Kristensen, John Aasted Soerensen
Filed: 2 Dec 18
Utility
Glucose-sensitive Albumin-binding Derivatives
14 Oct 20
This invention relates to glucose-sensitive albumin-binding diboron conjugates.
Thomas Kruse, Mikael Kofoed-Hansen, Martin Werner Borchsenius Muenzel, Henning Thoegersen, Per Sauerberg, Jakob Ewald Rasmussen, Carsten Behrens, Thomas Hoeg-Jensen, Vojtech Balsanek, Zuzana Drobnakova, Ladislav Droz, Miroslav Havranek, Vladislav Kotek, Milan Stengl, Ivan Snajdr, Hana Vanova
Filed: 7 Nov 18
Utility
Propylene Glycol-containing Peptide Formulations Which Are Optimal for Production and for Use In Injection Devices
7 Oct 20
The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated.
Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
Filed: 23 Jun 20
Utility
Regimen Adherence Measure for Insulin Treatment Based on Glucose Measurements and Insulin Pen Data
30 Sep 20
Systems and methods are provided for adjusting a standing insulin medicament dosage regimen for a subject.
Henrik Bengtsson, Tinna Bjoerk Aradottir
Filed: 21 Jun 17
Utility
Drug Delivery System with Multipolar Magnet and Sensor System
30 Sep 20
A drug delivery system comprises an indicator element and a sensor system.
Nikolaj Eusebius Jakobsen, Preben Mikael Nielsen, Nikolaj Frogner Krusell, Laurits Hoejgaard Olesen
Filed: 14 Jun 20
Utility
Antibodies and Use Thereof
30 Sep 20
The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils.
Peter Matthew Tessier, Samuel D. Stimple, Arne Staby
Filed: 30 Mar 20
Utility
Amplifying Beta Cell Differentiation with Small Molecules BET (Bromodomain And Extraterminal Family Of Bromodomain-Containing Proteins) Inhibitors
30 Sep 20
The present invention provides an in vitromethod for obtaining cells of the pancreatic endocrine lineage, comprising a step of culturing pancreatic progenitor cells, wherein said pancreatic progenitor cells are in a cell culture medium comprising at least one BET inhibitor.
Lukas Huijbregts, Raphael Scharfmann, Christian Honore
Filed: 29 Jun 17
Utility
an Injection Device with a Cleaning Reservoir
23 Sep 20
The invention relates to a medical injection device for injection of a liquid drug.
Bo Radmer, Lars Eilertsen, Bjoern Gullak Larsen, Nikolaj Thorsoe Kronborg
Filed: 9 Sep 18
Utility
Control of medical device using wireless communication
16 Sep 20
The present invention provides a system (1) comprising: a pen injection device (10) holding a specific type of medicament and comprising a dose expelling mechanism and pen communication means (15), a mobile communication unit (30) comprising mobile communication means (35) adapted to communicate with the pen communication means (15), and a software application program configured to determine a recommended type of medicament to be delivered to a user based on information indicative of a physiological condition of the user, wherein the pen injection device (10) further comprises indication means which in a first state indicates that the dose expelling mechanism is to remain idle and in a second state indicates that the dose expelling mechanism is available for operation, and wherein the mobile communication unit (30) is configured to, via a communication from the mobile communication means (35) to the pen communication means (15), a) prompt a change of state of the indication means from the second state to the first state in response to the recommended type of medicament to be delivered differing from the specific type of medicament, and/or b) prompt a change of state of the indication means from the first state to the second state in response to the recommended type of medicament to be delivered corresponding to the specific type of medicament.
Christian Peter Enggaard, Rune Ravn
Filed: 30 Oct 18
Utility
Crystal-free Oscillator for Channel-based High-frequency Radio Communication
16 Sep 20
The present invention relates to a crystal-free oscillator circuit (100) for channel-based high-frequency radio communication, the crystal-free oscillator circuit (100) comprising a crystal-free oscillator element (120) configured to provide a high-frequency reference signal (101), the high-frequency reference signal (101) having a frequency of at least about 1 GHz, and a phase-locked loop (PLL) circuit (110) having a feedback loop and comprising a PLL oscillator (120), wherein the phase-locked loop circuit (110) is configured to receive a high-frequency reference signal (101), to provide a feedback signal (102) in the feedback loop, and to provide a high-frequency output signal (103), the high-frequency output signal (103) being generated by the PLL oscillator (120′) in response to the high-frequency reference signal (101) and to the feedback signal (102) where the feedback signal (102) is dependent on an earlier instance of the output signal (103), wherein the crystal-free oscillator circuit (100) further comprises an adjustable frequency offset circuit (210) located in the feedback loop, the adjustable frequency offset circuit (210) comprising a frequency generator (200) and being configured to offset a frequency of the feedback signal (102) in response to an adjustment control signal (104), and wherein the crystal-free oscillator circuit (100) is configured to compensate for a temperature dependency of the crystal-free oscillator circuit (100) in response to a measured current operating temperature.
Carsten Bleser Rasmussen, Ching-Hua Yang, Ander Fernandez Garcia, Mikkel Schouenborg Grubbe
Filed: 29 Nov 18
Utility
Novel Insulin Derivatives and the Medical Uses Hereof
9 Sep 20
The present invention is in the therapeutic fields of drugs for medical conditions relating to diabetes.
Peter Madsen, Martin Muenzel, Claudia Ulrich Hjoerringgaard, Susanne Hostrup, Tine Glendorf, Mathias Norrman, Christian Fledelius
Filed: 24 Mar 20
Utility
a System for Assisting In Administration of a Drug
2 Sep 20
A system and kit for assisting a subject in administering an injectable drug by use of an injection device having communication means to communicate data at least about sizes of doses expelled and a timestamp for when each dose was expelled.
Prakarn Nisarat, Kirk Cornell
Filed: 29 Aug 18
Utility
Compounds For Use in NASH
26 Aug 20
The present invention relates to compounds for use in the prevention and/or treatment of NASH.
Jesper F. Lau, Thomas Kruse, Dorte Holst, Elisabeth Douglas Galsgaard, Jenny Louise Egecioglu Norlin
Filed: 12 Jun 19
Utility
Oligomer Extended Insulin-FC Conjugates
19 Aug 20
This invention is in the field of protein conjugates.
Tina Moeller Tagmose, Peter Madsen, Thomas Boerglum Kjeldsen, Lone Pridal, Leonardo De Maria, Zhaosheng Lin, Zhe Wan, Yuanyuan Zhang, Lennart Lykke, Martin Werner Borchsenius Muenzel, Janos Tibor Kodra
Filed: 3 Apr 18
Utility
Systems and Methods for Liquid Injection
5 Aug 20
Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided.
Robert S. Langer, Carlo Giovanni Traverso, Alex G. Abramson, Morten Revsgaard Frederiksen, Mikkel Oliver Jespersen, Brian Mouridsen, Jesper Windum, Mette Poulsen, Brian Jensen, Jorrit Jeroen Water, Mikkel Wennemoes Hvitfeld Ley, Xiaoya Lu
Filed: 30 Jan 20